Integer Holdings (NYSE: ITGR) has added Michael Coyle to its board of directors, assigning him to the audit, compensation, and technology strategy committees.
Coyle brings over 40 years of medtech leadership, including roles as president and CEO of iRhythm Technologies and head of Medtronic’s cardio and vascular group. He has held executive positions at St. Jude Medical and Eli Lilly and holds six U.S. patents for cardiovascular devices.
Integer board chair Pamela Bailey highlighted Coyle’s extensive industry experience and leadership as valuable to the company’s strategic growth. CEO Joseph Dziedzic emphasized Coyle’s expected contribution to strengthening Integer’s contract development and manufacturing outsourcing strategy.
Based in Plano, Texas, Integer is a global leader in medtech contract manufacturing.
Follow MEDWIRE.AI for medtech leadership and industry updates.
